Published in JAMA on September 20, 2006
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials (2009) 2.77
Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function. J Am Soc Nephrol (2012) 1.50
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol (2012) 1.42
Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol (2009) 1.40
Managing older adults with CKD: individualized versus disease-based approaches. Am J Kidney Dis (2011) 1.31
Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep (2011) 1.28
Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose. Trials (2013) 1.22
CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol (2012) 1.20
A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail (2010) 1.11
Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin (2008) 0.95
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial. Clin J Am Soc Nephrol (2010) 0.95
Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. J Am Heart Assoc (2015) 0.93
Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities. Contemp Clin Trials (2008) 0.91
Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis. Arthritis Rheum (2009) 0.90
Drug-eluting stents in patients with chronic kidney disease: a prospective registry study. PLoS One (2010) 0.90
Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J Physiol (2014) 0.90
Optimal method of coronary revascularization in patients receiving dialysis: systematic review. Clin J Am Soc Nephrol (2009) 0.90
Cardiorenal syndrome: still not a defined entity. Clin Exp Nephrol (2010) 0.88
Evidence-based statin prescription for cardiovascular protection in renal impairment. Clin Exp Nephrol (2011) 0.84
Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease. Clin Res Cardiol (2013) 0.83
The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin. Curr Cardiol Rev (2008) 0.83
Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward. Open Cardiovasc Med J (2011) 0.83
Age, exclusion criteria, and generalizability of randomized trials enrolling kidney transplant recipients. Transplantation (2011) 0.83
Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator. J Interv Card Electrophysiol (2012) 0.82
Temporal trends in mortality after coronary artery revascularization in patients with end-stage renal disease. Perm J (2014) 0.82
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes. Am J Kidney Dis (2008) 0.81
Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease. Am Heart J (2013) 0.81
Management and outcomes of renal disease and acute myocardial infarction. Am J Med (2010) 0.81
Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis (2014) 0.81
Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clin Exp Nephrol (2016) 0.81
Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome. BMC Nephrol (2013) 0.80
Impact of renal dysfunction on clinical outcomes of acute coronary syndrome. Yonsei Med J (2009) 0.79
Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis. BMC Nephrol (2013) 0.79
Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial. Trials (2014) 0.78
Current treatment in acute and chronic cardio-renal syndrome. Heart Fail Rev (2011) 0.78
Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency. Mayo Clin Proc (2010) 0.78
Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies. BMC Cardiovasc Disord (2009) 0.78
The importance of population-based performance measures. Health Serv Res (2007) 0.78
How do We Manage Coronary Artery Disease in Patients with CKD and ESRD? Electrolyte Blood Press (2014) 0.78
Setting the stage for acute-on-chronic kidney injury. Kidney Int (2008) 0.77
β2-Microglobulin and TIMP1 Are Linked Together in Cardiorenal Remodeling and Failure. Cardiorenal Med (2014) 0.77
Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study. BMC Cardiovasc Disord (2015) 0.77
Pharmacologic management of chronic reno-cardiac syndrome. Curr Heart Fail Rep (2013) 0.77
Pharmacological management of cardiorenal syndromes. Int J Nephrol (2011) 0.76
Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study. PLoS One (2016) 0.76
Chronic kidney disease and cardiovascular therapeutics: time to close the evidence gaps. J Am Coll Cardiol (2011) 0.75
Exclusion of Patients With Kidney Disease From Cardiovascular Trials. JAMA Intern Med (2016) 0.75
The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP). NDT Plus (2009) 0.75
Chronic kidney disease: Absence of evidence or evidence of absence? ACS treatment in CKD. Nat Rev Nephrol (2010) 0.75
Heart failure in subjects with chronic kidney disease: Best management practices. World J Cardiol (2010) 0.75
Does orlistat cause acute kidney injury? Ther Adv Drug Saf (2012) 0.75
Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. Am J Cardiol (2017) 0.75
Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. Pediatr Nephrol (2007) 0.75
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ (2012) 6.39
Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int (2011) 5.70
Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology (2013) 5.69
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA (2013) 5.27
Helping patients follow prescribed treatment: clinical applications. JAMA (2002) 5.18
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA (2002) 4.92
Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med (2002) 4.80
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med (2008) 4.70
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2002) 4.52
Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med (2012) 4.50
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
Consequences of inadequate sign-out for patient care. Arch Intern Med (2008) 4.39
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35
Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA (2009) 4.29
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med (2012) 4.02
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Time to treatment in primary percutaneous coronary intervention. N Engl J Med (2007) 3.95
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
Global trends in the rates of living kidney donation. Kidney Int (2009) 3.81
When choosing statin therapy: the case for generics. JAMA Intern Med (2013) 3.80
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am J Kidney Dis (2007) 3.47
A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int (2012) 3.47
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Transfers of patient care between house staff on internal medicine wards: a national survey. Arch Intern Med (2006) 3.43
Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med (2008) 3.42
Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA (2006) 3.40
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation (2010) 3.32
The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29
Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med (2009) 3.27
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure. JAMA Intern Med (2013) 3.26
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19
Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care (2007) 3.19
Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol (2003) 3.19